LAVA Therapeutics N.V. (LVTX) Misses Q3 EPS by 13c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q3 EPS of ($0.46), $0.13 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• NPR retracts story about Justice Alito retiring from Supreme Court
• Freedom Broker Starts John B. Sanfilippo & Son, Inc. (JBSS) at Hold
• US rail intermodal volumes surge 12.1% for sixth straight week of 5%+ gains